José Antonio García Erce/LinkedIn
Sep 13, 2025, 10:55
José Antonio García Erce: Platelet Program for the Management of the Patient’s Blood
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), shared on LinkedIn:
”In recent years, platelet consumption has increased by 26%, while plasma consumption has fallen by 37%.
With the expected and necessary increase in the activity of hematopoietic stem cell transplants and CAR-T cell therapies, a greater growth in demand is expected.
We Need a Platelet Program for the Management of the Patient’s Blood”
Stay informed on Platelet Program and more with Hemostasis Today.
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline